MAPK pathway and NIS in B-CPAP human papillary thyroid carcinoma cells treated with resveratrol

This publication has 23 references indexed in Scilit:

• The flavonoid quercetin reduces cell migration and increases NIS and E-cadherin mRNA in the human thyroid cancer cell line BCPAP
  Molecular and Cellular Endocrinology, 2021
• Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
  JAMA, 2013
• Cellular and molecular effects of resveratrol in health and disease
  Journal of Cellular Biochemistry, 2012
• Resveratrol Increases Iodide Trapping in the Rat Thyroid Cell Line FRTL-5
  Thyroid®, 2010
• The BRAFV600E Oncogene Induces Transforming Growth Factor β Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer
  Cancer Research, 2009
• Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms
  Archives of Biochemistry and Biophysics, 2009
• BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
  Endocrine Reviews, 2007
• The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer
  Annals of Surgery, 2007
• Molecular and Genotypic Characterization of Human Thyroid Follicular Cell Carcinoma–Derived Cell Lines
  Thyroid®, 2007
• Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells
  Neuroscience Letters, 1999